January 28, 2021
WCBP Tech Talk
At the start of the pandemic, Bio-Techne mobilized resources across its organization to help in the fight to understand and find solutions for the novel SARS-CoV-2 virus. As a result of the hard, dedicated work of employees around the world throughout the pandemic, we now offer a breadth of tools and solutions in the fight against COVID-19.
These solutions include manufacturing several key viral proteins, antibodies, and an emergency use authorized ELISA. We have also proudly brought several assays and tests online using our ProteinSimple platforms, not only for research use to understand the virus, but also in characterizing the immune response in COVID-19 positive serum samples that we will discuss today. These tools have and will continue to play important roles in support of vaccine research and development.
WCBP Tech Talk
At the start of the pandemic, Bio-Techne mobilized resources across its organization to help in the fight to understand and find solutions for the novel SARS-CoV-2 virus. As a result of the hard, dedicated work of employees around the world throughout the pandemic, we now offer a breadth of tools and solutions in the fight against COVID-19.
These solutions include manufacturing several key viral proteins, antibodies, and an emergency use authorized ELISA. We have also proudly brought several assays and tests online using our ProteinSimple platforms, not only for research use to understand the virus, but also in characterizing the immune response in COVID-19 positive serum samples that we will discuss today. These tools have and will continue to play important roles in support of vaccine research and development.
Speaker:
 |
Chris Heger, Ph.D. Director, Applications Science, Analytical Solutions Division ProteinSimple, a Bio-Techne brand |
